Trademarkia Logo

Canada

C$
Biosimilar Logo
ADVERTISED

on 9 May 2025

Last Applicant/ Owned by

Teva Pharmaceuticals USA, Inc.

400 Interpace Parkway, Building AParsippany, NJ 07054

US

Serial Number

2143821 filed on 28th Oct 2021

Registration Number

TMA1311925 registered on 9th May 2025

Registration expiry Date

9th May 2035

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

Biosimilar Logo

Trademark usage description

pharmaceutical preparations for the treatment of autoimmune diseases. injectors for medical purposes; medical fluid injectors.

Vienna Information


26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

29 . 1 . 4

BlueBleu

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of autoimmune diseases.


Classification kind code

11

Class [010]
Injectors for medical purposes; medical fluid injectors.


Classification kind code

11

Mark Details


Serial Number

2143821

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 190
on 9th May 2025
Registration Pending
Submitted for opposition 55
on 9th May 2025
Registered
Submitted for opposition 42
on 19th Feb 2025
Advertised
Submitted for opposition 26
on 24th Jan 2025
Approved
Submitted for opposition 27
on 24th Jan 2025
Approval Notice Sent
Submitted for opposition 22
on 16th Jan 2025
Search Recorded
Submitted for opposition 287
on 17th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 28th Oct 2021
Filed
Submitted for opposition 1
on 28th Oct 2021
Created
Submitted for opposition 31
on 28th Oct 2021
Formalized